Lee Financial’s Royalty Pharma RPRX Stock Holding History

Lee Financial’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,300	Closed	-$36.5K	–	678
2023 Q4	$36.5K	Hold	1,300	–	–	0.01%	259
2023 Q3	$35.3K	Hold	1,300	–	–	0.01%	252
2023 Q2	$40K	Hold	1,300	–	–	0.01%	239
2023 Q1	$46.8K	Sell	1,300 -60	-4%	-$2.23K	0.01%	235
2022 Q4	$53.7K	Hold	1,360	–	–	0.01%	247
2022 Q3	$54K	Sell	1,360 -4	-0.3%	-$171	0.01%	245
2022 Q2	$58K	Buy	1,364 +64	+5%	+$2.62K	0.01%	234
2022 Q1	$51K	Hold	1,300	–	–	0.01%	240
2021 Q4	$52K	Hold	1,300	–	–	0.01%	252
2021 Q3	$47K	Hold	1,300	–	–	0.01%	231
2021 Q2	$53K	Hold	1,300	–	–	0.01%	223
2021 Q1	$57K	Hold	1,300	–	–	0.01%	223
2020 Q4	$65K	Buy	+1,300	New	+$55.2K	0.02%	189

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lee Financial's RPRX Position: Q1 2024 in Review

Lee Financial sold out of Royalty Pharma (RPRX) in Q1 2024, closing a stake of 1,300 shares — an estimated $36.5K sold.

Lee Financial first reported a position in RPRX in Q4 2020 and held it in 13 quarters. The position peaked at $65K in Q4 2020. 378 funds tracked by Wall St. Rank hold RPRX as of Q1 2024.

Lee Financial reported no remaining Royalty Pharma position as of Q1 2024 after selling out during the quarter.
Lee Financial sold 1,300 Royalty Pharma shares in Q1 2024, an estimated $36.5K.
Lee Financial first reported a position in Royalty Pharma in Q4 2020 and held it in 13 quarters.
Lee Financial's Royalty Pharma position peaked at $65K in Q4 2020.
378 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.